2018
Marijuana Use in Adults Living with Sickle Cell Disease
Roberts JD, Spodick J, Cole J, Bozzo J, Curtis S, Forray A. Marijuana Use in Adults Living with Sickle Cell Disease. Cannabis And Cannabinoid Research 2018, 3: 162-165. PMID: 30014039, PMCID: PMC6044416, DOI: 10.1089/can.2018.0001.Peer-Reviewed Original ResearchSickle cell diseaseCell diseaseMedical marijuanaMarijuana useUrine drug testsPossible therapeutic effectsUrine drug testingAcademic medical centerTertiary careTherapeutic effectMedical CenterPatient's requestPatientsDiseaseQualifying conditionsDrug testsDrug testingCannabinoidsActive constituentsMarijuanaMedicinal indicationsPhencyclidineAdultsInstitutional recordsRecreational use
2012
Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery
Yonkers KA, Forray A, Howell HB, Gotman N, Kershaw T, Rounsaville BJ, Carroll KM. Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery. General Hospital Psychiatry 2012, 34: 439-449. PMID: 22795046, PMCID: PMC3428516, DOI: 10.1016/j.genhosppsych.2012.06.002.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyMotivational enhancement therapyMET-CBTEnhancement therapyBehavioral therapySubstance useHazardous substance useBrief advicePregnant substance usersMonths postdeliverySubstance usersHospital outpatient clinicSubstance-using womenWeeks of pregnancySubstance misuseSimilar therapeutic effectsPercentage of daysSelf-reported percentageBiological measuresPreterm birthStudy nursesPrimary outcomeOutpatient clinicPrenatal careTherapeutic effect